✕ Stäng

Dudi Warsito

Skribent

Dudi har en MSc i molecular life sciences från Stockholms universitet och en PhD i medicinsk vetenskap från Karolinska Institutet.

Dudi har över åtta års erfarenhet av cancerforsning vid Karolinska Institutet och varit medförfattare till flera vetenskapliga artiklar.

Characterization of an activating R1353H insulin-like growth factor 1 receptor variant in a male with extreme tall height. https://www.ncbi.nlm.nih.gov/pubmed/29789409

Telomerase promoter mutations and copy number alterations in solitary fibrous tumours. https://www.ncbi.nlm.nih.gov/pubmed/29703757

Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage. https://www.ncbi.nlm.nih.gov/pubmed/28924044

Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors. https://www.ncbi.nlm.nih.gov/pubmed/28471449

SUMO-modified insulin-like growth factor 1 receptor (IGF-1R) increases cell cycle progression and cell proliferation. https://www.ncbi.nlm.nih.gov/pubmed/28112398

Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein. https://www.ncbi.nlm.nih.gov/pubmed/27275536

The Nucleus-Localized Epidermal Growth Factor Receptor Is SUMOylated. https://www.ncbi.nlm.nih.gov/pubmed/26244656

Nuclear translocation of IGF-1R via p150(Glued) and an importin-β/RanBP2-dependent pathway in cancer cells. https://www.ncbi.nlm.nih.gov/pubmed/24909165

Nuclear IGF1R is a transcriptional co-activator of LEF1/TCF. https://www.ncbi.nlm.nih.gov/pubmed/22261717

Senaste Nytt